| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| somatropine (efficacité biologique relative) 1,8 UI (0,6 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 1,2 UI (0,4 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 0,6 UI (0,2 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), poudre et diluant pour injection avec nécessaire de reconstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 12 UI (4 mg), fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 2,4 UI (0,8 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 3 UI (1 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 18 UI (6 mg), cartouche de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 72 UI (24 mg), cartouche de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 3,6 UI (1,2 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 4,2 UI (1,4 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 4,8 UI (1,6 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 5,4 UI (1,8 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 6 UI (2 mg), seringue préremplie de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| Somatropin(rbe) 3iu(1mg) powder for conventional release solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 200 microgram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 200 microgram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 12 milligram/1 cartridge powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 12 milligram/1 cartridge powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 600 microgram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 600 microgram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.2 milligram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.2 milligram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.6 milligram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.6 milligram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.4 milligram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.4 milligram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.3 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.3 milligram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.8 milligram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 1.8 milligram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 2 milligram/1 syringe powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 2 milligram/1 syringe powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 24 milligram/1 cartridge powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing precisely somatropin(rbe) 24 milligram/1 cartridge powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing somatropin(rbe) in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing somatropin(rbe) (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing only somatropin(rbe) (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
| Product containing only somatropin(rbe) in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rbe) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]